MSL Activity Capture
MSL activity capture records scientific interactions and insights, with access restricted from commercial teams to preserve the non-promotional boundary.
Custom Software
Pharma Medical Affairs Software Development
Medical affairs software supports MSL field activity, investigator-initiated trial management, medical information inquiries, scientific engagement planning, and grants administration. Its defining requirement is separation from commercial systems, because scientific exchange operates under different rules than promotion and shared infrastructure undermines that distinction.
Medical affairs exists partly because certain communications are permissible only outside a promotional context, which makes system architecture a compliance matter rather than an IT preference. Taction Software builds pharma medical affairs software where separation from commercial platforms is structural, so the boundary holds under the commercial pressure that inevitably tests it.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is Pharma Medical Affairs Software
Pharma medical affairs software supports the scientific function: medical science liaison activity capture, medical information inquiry handling, investigator-initiated trial and grant management, KOL and scientific engagement planning, publication planning, and congress activity. What separates it from commercial tooling is not features but governance: MSL interactions are scientific exchange, not promotion, and shared systems with commercial teams compromise that position. Our work sits within our broader pharma and life sciences practice.
Medical Information Inquiries
Medical information workflow handles unsolicited requests including off-label questions, which may be answered through documented medical channels rather than commercial ones.
Investigator-Initiated Trials
IIT management covers proposal review, funding decisions, and study oversight, with scientific merit governing rather than commercial considerations.
Grants and Educational Support
Medical grants administration documents independent review, since educational funding must not function as inducement under Anti-Kickback constraints.
Scientific Engagement Planning
Scientific engagement planning coordinates KOL interaction across medical teams without merging into commercial targeting infrastructure.
Publication and Congress Planning
Publication planning tracks manuscripts, presentations, and congress activity, supporting transparent scientific communication commitments.
Core Medical Affairs Services
Our pharma medical affairs services cover MSL tooling, inquiry management, IIT workflow, grants administration, and engagement planning, all built with commercial separation designed in. The architectural question we settle first is data boundaries: which records medical may see, which commercial may see, and what genuinely must be shared such as transfer-of-value reporting. Engagements typically open with that boundary definition alongside compliance stakeholders.
01
MSL Field Application
MSL applications capture interactions and insights offline, since scientific meetings occur in clinical settings where connectivity is unreliable.
02
Medical Information Platform
Inquiry management routes questions to medical information specialists with response libraries, documented approvals, and complete interaction records.
03
IIT and Grant Workflow
IIT workflow manages submission, scientific review, contracting, and milestone tracking with decision rationale documented for audit.
04
Insight Management
Scientific insights captured by MSLs are structured and routed to medical and research teams under access rules that exclude commercial use.
05
Engagement Data Platform
Where CRM anchors medical engagement, our healthcare CRM work covers separate instance configuration from commercial systems.
06
Evidence and Publication Support
Evidence work connects with real world evidence platform capabilities supporting scientific communication and publication planning.
Benefits of Purpose-Built Medical Affairs Software
The benefits concentrate in defensible separation, structured insight capture, and documented independence for funding decisions. Medical affairs teams frequently operate on commercial platforms with permission-based separation, which is difficult to defend when an auditor asks how scientific exchange stayed non-promotional. We publish no figures on engagement quality, insight volume, or scientific impact, because those depend entirely on therapeutic area, product stage, and team structure.
Defensible Compliance Boundary
Architectural separation is demonstrable in a way permission settings on a shared commercial platform are not during audit or investigation.
Structured Scientific Insight
Insight capture routes field intelligence to medical and research teams, preserving value that otherwise stays in individual MSL notes.
Documented Funding Independence
Independent review records for IITs and grants demonstrate scientific merit governed decisions rather than commercial relationships.
Better Inquiry Handling
Structured medical information workflow ensures unsolicited requests receive documented, consistent responses through appropriate channels.
Coordinated Scientific Engagement
Medical teams coordinate KOL interaction without duplicating commercial contact, reducing burden on the experts both functions engage.
Transparent Publication Tracking
Publication planning supports transparency commitments and disclosure obligations across manuscripts, presentations, and congress activity.
Our Medical Affairs Software Process
We deliver pharma medical affairs projects in gated phases so medical, compliance, and IT stakeholders approve direction before engineering cost accumulates. Discovery begins with boundary definition: what medical and commercial may each access, and what must be shared. That determines architecture, and settling it late produces expensive rework. Development is iterative with MSL input, since field tooling designed without them produces low-quality insight capture.
Discovery and Boundary Definition
Discovery defines data boundaries between medical and commercial with compliance, since this determines architecture and cannot be settled late.
Separation Architecture Design
Separation is implemented structurally through distinct data stores and access paths rather than through role permissions on shared infrastructure.
MSL Workflow Design
We design field tooling with MSLs directly, since insight quality depends on capture being fast enough to complete after a scientific exchange.
Inquiry Workflow Development
Medical information workflow is built with response governance, documenting approval and delivery for every inquiry including off-label requests.
Grant Review Implementation
Review workflow documents independence and scientific rationale, producing the record that demonstrates funding decisions were merit-based.
Rollout and Ongoing Support
Rollout expands by function with compliance monitoring, boundary auditing, and continuing support as therapeutic portfolios evolve.
Technology and Compliance
Medical affairs software operates under the promotional and non-promotional distinction that defines the function, Anti-Kickback constraints on grants and engagement, Open Payments reporting which applies to medical transfers of value as much as commercial ones, and privacy law governing HCP data. Manufacturers are generally not HIPAA covered entities, so HCP data falls under state privacy law. Taction holds ISO 27001 certification. The requirement that shapes architecture most is separation, which must be structural to be defensible.
Commercial Separation Architecture
Separation uses distinct data stores and access paths, since permission-based separation on shared commercial infrastructure is difficult to defend.
Scientific Exchange Boundaries
Scientific exchange operates under different rules than promotion, and system design must not blur that line through shared content or targeting.
Open Payments Reporting
Transfer of value from medical activity including grants, consulting, and travel is reportable, so capture applies to medical as much as commercial.
Grant Independence Documentation
Independent review documentation for educational and research funding demonstrates decisions were merit-based rather than commercially influenced.
Privacy Framework Accuracy
HCP data is generally governed by state privacy law rather than HIPAA. Our HIPAA compliance practice explains the boundary.
Deployment Security
Deployments run in your cloud tenancy or hybrid, with network segmentation, signed container images, and documented penetration testing before release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare and life sciences software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant discipline here is building the separation properly even when a client already owns a commercial platform that could technically host medical affairs. The cheaper option is frequently the less defensible one. Our leadership brings more than 20 years of personal experience in the field.
01
Structural Separation
We build medical and commercial separation architecturally rather than through permissions, because the boundary must hold under audit scrutiny.
02
Field Tooling Experience
We design MSL applications with field scientists directly, since insight capture quality depends entirely on usability after a real interaction.
03
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare and life sciences rather than treating them as one vertical among several.
04
Regulatory Framing Accuracy
We frame privacy obligations correctly for manufacturer HCP data rather than applying provider assumptions that do not govern it.
05
Enterprise Integration Depth
Our integration work spans scientific and operational systems while preserving boundaries that shared integration would otherwise erode.
06
Certified Security Posture
ISO 27001 certification means security controls are documented and auditable, supporting pharmaceutical vendor assessment efficiently.
Pricing
Pharma medical affairs software pricing depends on scope, whether MSL field tooling is included, IIT and grant workflow complexity, and separation architecture requirements. Building separate infrastructure costs more than extending a commercial platform, and we recommend it anyway where the compliance position warrants. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Platform licensing, cloud infrastructure, and content system costs are separate from engineering and itemized clearly.
MVP or Single Module
An MVP covering medical information inquiry workflow or MSL activity capture typically runs $40,000 to $80,000.
Full Platform Build
A full platform with MSL tooling, inquiry management, IIT workflow, and engagement planning typically falls between $80,000 and $200,000.
Enterprise Deployment
Enterprise engagements covering multi-therapeutic-area governance, grants administration, and full separation architecture start at $200,000.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and documented boundary model reviewed with compliance.
Cost Drivers to Expect
Separation architecture, MSL field scope, IIT workflow complexity, and therapeutic area count are the largest variables, identified during discovery.
Ongoing Support Costs
Post-launch boundary auditing, workflow updates, and support are quoted separately as a retainer sized to team size and portfolio breadth.
Get Started
If you are evaluating pharma medical affairs software for MSL activity, medical information workflow, IIT management, or scientific engagement planning, the fastest next step is a discovery call with our team. We will define the medical and commercial boundary with your compliance function, then return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Medical affairs and compliance leaders evaluating pharma medical affairs software usually ask whether separate systems are genuinely necessary, how off-label inquiries are handled, and whether Open Payments applies to medical activity. The answers below reflect how we scope these projects.
For a defensible compliance position, yes. Permission-based separation on a shared commercial platform is difficult to explain to an auditor asking how scientific exchange remained non-promotional. Structural separation costs more and is substantially easier to defend, which is why we recommend it despite the expense.
Through documented medical information workflow responding to unsolicited requests, which is permissible in that context and not in a promotional one. The system records the request, the approved response, and delivery, since documentation is what distinguishes appropriate medical information from promotional communication.
Yes. Transfers of value from medical activity including consulting, advisory participation, grants, travel, and meals are reportable in the same way commercial transfers are. Medical affairs teams sometimes underestimate this, so we build capture into medical workflows rather than assuming commercial systems cover it.
An MVP runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise deployments with full separation architecture start at $200,000. Separate infrastructure is a real cost premium over extending a commercial platform, and it buys a defensible position.
Not in a properly designed system. Scientific insights captured during medical exchange are routed to medical and research functions, and routing them to commercial teams would convert the interaction into something closer to promotion. Access rules enforce this structurally rather than by policy.
Generally not. Manufacturers are typically not covered entities, and HCP professional data falls under state privacy law rather than HIPAA. Patient data reaching medical affairs through support programs or studies is a different question, handled under the applicable authorization or protocol framework.